GL1X · GenesisL1 explorer

Research workbench

Structure of SARS-cov-2 3CL protease in complex with inhibitor 7C

Analyse Structure of SARS-cov-2 3CL protease in complex with inhibitor 7C in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7T45
Type
protein
Length
595 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTD1
Ligands
EW9
Pockets
7 · best druggability 0.73

Structure

x-ray diffraction · 2 distinct chains · 26% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A3C-like proteinase (EC 3.4.22.69)protein29726% helix, 29% strandP0DTD1
B3C-like proteinase (EC 3.4.22.69)protein29827% helix, 29% strandP0DTD1

Ligands and binding sites

  • EW9 · (1S,2S)-2-{[N-({[7-(tert-butoxycarbonyl)-7-azaspiro[3.5]nonan-2-yl]oxy}carbonyl)-L-leucyl]amino}-1-hydroxy-3-[(3S)-2-oxopyrrolidin-3-yl]propane-1-sulfonic acid · ligand · 2 copies · chains A, B
  • PG4 · Tetraethylene glycol · additive · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110110.730.7681empty
21900.530.7837empty
31650.490.7823EW9
41600.480.7722EW9
5950.340.7326empty

Interfaces

1 interface between chains.

  • A–B · 873 Ų buried · 15 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (covalent ligand).

Compared structures

  • 7T45 · Structure of SARS-CoV-2 3CL protease in complex with inhibitor 7c · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.